See the latest vacancies and find out about working for MSF UKJobs in the UK
MSF Scientific Days 2020: Guidelines for submitting an innovation project abstract
Total abstract wordcount: 400 words.
Submission deadline: 8th January 2020.
What is an innovation project
For the purposes of MSF Scientific Days, an innovation is the creation and implementation of new or novel products, services or strategic approaches. Or an innovation can mark the advance of an existing product, service, or strategy.
The project doesn't have to be medical in nature, but it must improve the way MSF provides medical care (for example, developing new systems for regenerating boreholes).
- Abstracts and demos
We are looking for abstract and/or demo submissions for the MSF Scientific Days – innovations that show evidence of impact, either in the outcomes they bring or in the development of improved processes or understanding for MSF.
- What kind of innovation projects can be submitted as an abstract?
When you submit your abstract, you need to indicate which stage your innovation project is at (see the diagram below):
- Initiation or
- Development or
We welcome abstracts from all the above stages. However, we don’t accept projects which are at the idea or design stage. The MSF Scientific Days are special because they focus on improving our work in the field through evidence and rigorous evaluation / analysis.
What does this mean? It means that, ideally, you have developed and tested your innovation (i.e. gathered data to analyse whether it worked and the impact it had or could have), and can submit an abstract based on the outcomes, how you achieved them and what they might mean for MSF’s work. A good example can be found here.
We are as interested in ‘failed’ projects as in successful ones. We know that not all innovations achieve the hoped for outcome or impact - we need to ‘fail forward’ and learn. See a good example here.
You can submit an abstract for a project at the Initiation or Development stage as long as you can include learnings from analysis of data. These learnings could be in the form of a new process for MSF or a new perspective on a field challenge. Here are two examples:
Luc has an idea of how to solve a field challenge, but through his analysis of that challenge he finds that it is actually a symptom of a wider problem. He then explores this wider problem and generates a new idea of how to solve it. Because Luc’s project already has relevance for MSF’s work and is based on evidence and analysis, he can submit it as an abstract as long as he can describe how he obtained the evidence and what analysis he did.
Pascale is creating a new tool for nurses in the field. She tests a new approach to developing this tool and subsequently discovers a much more effective way to gather and communicate MSF nurses’ requirements to the design team, meaning time and money are saved. If she can demonstrate through data how that process has improved upon what already exists, she can submit it as an abstract. See an example of this here.
What kind of innovation projects can be submitted as a demo?
The demo session is for innovative projects that are ‘work in progress’, where you might not yet have results from testing or implementation. It’s a great opportunity to present your project more informally and get feedback from the MSF Scientific Days audience. Demos may also be offered to presenters of oral presentations where the Editorial Committee sees additional benefit from a hands-on demonstration.
If you do have results from testing or implementation from your project, please do submit it as an abstract for presentation (see below for details).
What are the next steps?
- Submit your abstract
Please be aware that all abstracts must be relevant for a medical humanitarian audience. Submissions from other disciplines are welcome, but they must have the objective of improving medical impact.
Discuss your project with a mentor first
We recognise that those of you not involved in research may be unfamiliar with the concept of submitting work in the form of an abstract. If this is the case, and you would like support with the process (or even if you would like to discuss whether your work is relevant to submit), please get in touch via firstname.lastname@example.org. Please get in touch well in advance of the abstract deadline so that we have time to help.
Your introduction should describe the background to your project:
- What challenge or opportunity is your project addressing?
- Why does that challenge or opportunity matter and why should MSF address it?
- What is/was the objective for the project – i.e. what change is/was it expected to bring?
- What’s different about what you’re doing? Has anyone tried it before? If so, what happened?
Your methods section should describe how you collected and analysed your results:
- How did you plan to compare the resulting change against what exists already?
- What indicators of success did you measure (for example, data on quality of care, reach, price, efficiency, user experience etc.) and how did you analyse them?
- How did you collect your data? What were your sources?
- If anything unexpected happened during your project, how did you measure its impact?
- Make sure your methodology is clear – it is important to show that the evidence you are providing was gathered in a rigorous manner.
Your results section should describe the data with which you evaluated your project and what your analysis of this data showed:
- What change have you seen from the work you’ve done?
- Are you sure that your work caused this change? (it’s all right if not, but discuss this question).
- Did your results show whether your innovation offers a better/cheaper/faster/easier solution compared to other/existing approaches? How did it do so and was it in the way you were expecting? If anything unexpected happened what was it and how did it affect your project?
- Describe other factors you considered that might have had an impact on your results. If the project changed from its initial objective or process, what evidence did you use to make that decision? What was the result of the change?
- Are people still using it? Where? What feedback have you had from ops/programmes?
- Is the innovation being used beyond the initial context (has it already scaled)? If so, to what level (other projects, countries, MSF Operational Centres, externally)? If not, is something blocking uptake? Is it context-specific?
- If you started this project all over again, what would you do differently - what are the lessons learned?
Your conclusions should describe the implications of your work and any recommendations you may have for its future:
- Is your project ongoing? If yes, what are the next steps? If the project has ended, did it reach its objectives or was it stopped early?
- Whether failure or success, what did you learn from this and what are the implications (potential impact) of your work, for practice, policy, programmes or advocacy for MSF or others?
- What should happen next in this area of innovation / within your project?
- How should the learning from your innovation project be used by MSF?
All submissions must contain an ethics statement. Innovation projects can involve ethical risks and have consequences for populations even if human participants are not directly involved, therefore the Project Sponsor (or whoever is responsible for oversight of the initiative) should consult the MSF innovation ethics framework to ensure their project is ethically sound.
If your MSF innovation project involved human subjects or their data, this must have ethics oversight by the relevant Medical Director from the Operational Centre responsible for the research. Please see here for MSF ERB (Ethics Review Board) guidance.
In the submission system, you will be asked whether your project involved human participants or their data (for further guidance on this, please consult our webpage on the importance of ethics).
If your project did include human participants or their data, you will need to choose from one of the options below:
- This innovation project is approved by an Ethics Review Board (ERB) – please specify:
- This innovation project meets the exemption criteria for ERB review – it was conducted with permission from:
- Other – please explain:
If your project did not include human participants, you will be asked to confirm that you have consulted the Innovation Ethics Framework (or equivalent) to help identify and mitigate potential harms.
- Conflicts of interest
You will be asked to declare any conflicts of interest. Failure to disclose these might lead to withdrawal of abstracts or presentations from MSF Scientific Days. All conflicts of interest will be published in the conference booklet.
A conflict of interest exists when professional judgement concerning a primary interest (such as patients’ welfare or validity of research) may be influenced by a secondary interest (such as financial gain).
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within 3 years of beginning the work submitted.
Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships or rivalries, academic competition, or intellectual beliefs. A conflict can be actual or potential, and full disclosure is best practice.
Agreements between authors and study sponsors that interfere with authors’ access to all of a study’s data, or that interfere with their ability to analyse and interpret the data and to prepare and publish work independently, may represent conflicts of interest, and should be avoided.
All submissions must include disclosure of all relationships that could be viewed as presenting a potential or actual conflict of interest.
If there are no conflicts of interest, authors should tick the box to state that there are none.
Please note, all submitted MSF abstracts will be sent to the relevant Medical Director so that they are aware of what has been submitted.
- Data reporting standards
If you have quantitative data, give actual numbers, not only percentages. Do not use phrases like ‘around half’ unless supported by underlying numbers. Ensure that the denominator is clear throughout the analysis and include where needed. Means need standard deviations (SDs); medians need interquartile ranges (IQRs). Give 95% confidence indicators (CIs) and p-values where appropriate.
Abstract submission deadline: 8th January 2020
If you have been successful in securing a demo or an oral presentation at the MSF Scientific Days International (London) event you will be contacted by 10th February and asked to confirm participation. Authors of selected abstracts must be available to present in person in London on 14th May 2020.
If you have not been successful, you will be contacted by 24th February but you may still secure a place at the Asia, Latin America or Southern Africa events.
Abstract editing – oral presentation
You will receive an edited abstract in week commencing 18th February and will have 1 week to respond – the corresponding authors must be available to revise and respond to questions during this time. If there is any difficulty in responding, authors should contact the MSF Scientific Days team (email@example.com) as soon as possible.
Oral presentations – assistance deadline
If assistance is required with presentation slides they must be sent by 17th April.
Oral presentations – submission deadline
Slides or other materials for oral presentations must be sent by 1st May 2020.
Authors must be available in the following week to respond to any comments/queries.
Presentation coaching will be available online or in person prior to MSF Scientific Days. All presenters are encouraged to make the most of the training to ensure that research is communicated as clearly as possible.
Get in touch
If you have any questions, please get in contact with us: firstname.lastname@example.org